Corcept Therapeutics Incorporated (NASDAQ: CORT) Q1 2023 Earnings Call dated May. 03, 2023 Corporate participants: Atabak Mokari -- Chief Financial Officer Charlie
Corcept Therapeutics Incorporated
-(CORT)
XNAS:CORT
Corcept Therapeutics Incorporated (CORT) Q4 2022 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2022 Earnings Call dated Feb. 28, 2023. Corporate Participants: Atabak Mokari -- Chief Financial Officer Charles Robb -- Chief Business Officer
Corcept Therapeutics Incorporated (CORT) Q3 2022 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2022 Earnings Call dated Nov. 03, 2022. Corporate Participants: Atabak Mokari -- CFO Joseph Belanoff -- CEO Sean Maduck -- President of Endocrinology
Corcept Therapeutics Incorporated (CORT) Q4 2021 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q4 2021 earnings call dated Feb. 15, 2022 Corporate Participants: Atabak Mokari -- Chief Financial Officer Charles Robb -- Chief Business
Corcept Therapeutics Incorporated (CORT) Q3 2021 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q3 2021 earnings call dated Nov. 03, 2021 Corporate Participants: Atabak Mokari -- Chief Financial Officer Charles Robb -- Chief Business
Corcept Therapeutics Incorporated (CORT) Q4 2020 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q4 2020 earnings call dated Feb. 08, 2021 Corporate Participants: Charles Robb -- Chief Financial Officer Joseph K. Belanoff -- Chief
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q1 2020 Earnings Call Transcript
Corcept Therapeutics Incorporated (CORT) Q1 2020 earnings call dated May 04, 2020 Corporate Participants: Charles Robb -- Chief Financial Officer Joseph K Belanoff -- Chief Executive